<DOC>
	<DOC>NCT01332539</DOC>
	<brief_summary>observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective. As control group, 120 patients with controlled partial epilepsy will be enrolled. The objective of the study is to describe the burden of illness in this epileptic population both in terms of costs and of quality of life. Costs and quality of life will be also compared between the two populations.</brief_summary>
	<brief_title>An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy</brief_title>
	<detailed_description>observational, non-interventional study in 120 patients with drug-resistant partial epilepsy, comprising two phases: a 3-month retrospective and a 6-month prospective.</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<criteria>Outpatients Diagnosis of partial epilepsy, defined as active, drugresistant in accordance to the 2010 ILAE (International League Against Epilepsy) definition and actually taking an addon therapeutic regimen. Able and willing to give the written informed consent (to be obtained before any study assessment) For each drugresistant patient, will be enrolled a patient with the same diagnosis and actually taking an addon therapy but with controlled epilepsy according to the 2010 ILAE definition. Patient currently included in a clinical trial for an AED (AntiEpileptic Drug) Hospital record data on epilepsy not available in the Investigator's files Patient unable to fill in selfquestionnaires (quality of life instrument) Patient currently hospitalized Patient who, according to the Investigator's judgment, is not able to follow the study procedures</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>